Autor: |
Zhu, Shen, Guo Wen, Cao, Ji, Wang, Jie, Pan, Ai Ming, Shi, Zhu, Zhu |
Rok vydání: |
2020 |
Předmět: |
|
Zdroj: |
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae. 42(1) |
ISSN: |
1000-503X |
Popis: |
Based on our experience in treating one patients with non-small cell lung cancer complicated with hyperthyroidism,the following considerations in immunotherapy and pharmaceutical care are proposed:role of iodine contrast and contrast agent selection in patients with hyperthyroidism;selection of hemostatic agents and assessment of thrombosis risk in patients with hemoptysis caused by tumor invasion of bronchus;influence of glucocorticoid use on the treatment with programmed cell death-1(PD-1)inhibitor and the role of PD-1 inhibitors in patients with a history of hyperthyroidism;education methods for patients refuse to receive opioids.The participation of clinical pharmacists in the Multiple Disciplinary Team and the multi-dimensional pharmaceutical monitoring for patients can improve the safety and rationality of medications. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|